Total assets increased 22.2%
Total assets changed +22.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$801.6M→$979.8M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CNS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 62.0%
Free-cash-flow proxy changed -62.0% from the comparable as-filed period.
$52.6M→$20.0M2 prior comparisons
Operating cash flow decreased 62.1%
Operating cash flow changed -62.1% from the comparable as-filed period.
$55.1M→$20.9M2 prior comparisons
Cash & equivalents decreased 32.6%
Cash & equivalents changed -32.6% from the comparable as-filed period.
$98.1M→$66.1M2 prior comparisons
Capital expenditure decreased 64.7%
Capital expenditure changed -64.7% from the comparable as-filed period.
$2.5M→$879,0002 prior comparisons
Operating cash flow / net income decreased 62.6%
Operating cash flow / net income changed -62.6% from the comparable as-filed period.
1.32→0.492 prior comparisons
Operating income increased 4.4%
Operating income changed +4.4% from the comparable as-filed period.
$48.9M→$51.1M2 prior comparisons
Shares outstanding increased 0.8%
Shares outstanding changed +0.8% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
51,007,541→51,432,9228 prior comparisons
Net income increased 1.3%
Net income changed +1.3% from the comparable as-filed period.
$41.7M→$42.2M2 prior comparisons
Stockholders' equity increased 10.4%
Stockholders' equity changed +10.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$550.3M→$607.7M4 prior comparisons
Stock-based compensation decreased 12.7%
Stock-based compensation changed -12.7% from the comparable as-filed period.
$12.3M→$10.8M2 prior comparisons
Total assets increased 20.0%
Total assets changed +20.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$751.0M→$901.0M4 prior comparisons
Net income increased 33.9%
Net income changed +33.9% from the comparable as-filed period.
$36.8M→$49.3M2 prior comparisons
Operating income increased 21.8%
Operating income changed +21.8% from the comparable as-filed period.
$43.3M→$52.8M2 prior comparisons
Cash & equivalents decreased 38.0%
Cash & equivalents changed -38.0% from the comparable as-filed period.
$95.4M→$59.2M2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +199.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$67.6M→$67.4M3 prior comparisons
Shares outstanding increased 0.8%
Shares outstanding changed +0.8% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
50,996,660→51,421,5338 prior comparisons
Stockholders' equity increased 11.5%
Stockholders' equity changed +11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$528.5M→$589.4M4 prior comparisons
Operating cash flow / net income changed across a sign change
Operating cash flow / net income changed +174.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
-1.84→1.372 prior comparisons
Stock-based compensation decreased 7.2%
Stock-based compensation changed -7.2% from the comparable as-filed period.
$12.2M→$11.3M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.